QuantRx Biomedical Corporation
QTXB · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $43 | $61 | $202 | $236 |
| SG&A Expenses | $43 | $61 | $202 | $236 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $43 | $61 | $202 | $236 |
| Operating Income | -$43 | -$61 | -$202 | -$236 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$217 | -$192 | -$420 | -$501 |
| Pre-Tax Income | -$260 | -$253 | -$622 | -$737 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$477 | -$469 | -$820 | -$737 |
| % Margin | – | – | – | – |
| EPS | -0.006 | -0.006 | -0.01 | -0.009 |
| % Growth | -1.7% | 42.3% | -10.6% | – |
| EPS Diluted | -0.006 | -0.006 | -0.01 | -0.009 |
| Weighted Avg Shares Out | 78,696 | 78,696 | 78,696 | 78,696 |
| Weighted Avg Shares Out Dil | 78,696 | 78,696 | 78,696 | 78,696 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $217 | $217 | $198 | $232 |
| Depreciation & Amortization | $43 | $61 | $202 | $11 |
| EBITDA | $0 | -$36 | -$202 | -$225 |
| % Margin | – | – | – | – |